Moreover, in prostate cancer cells, RHPN2 mRNA and protein expression were reduced upon miR-205 mimic treatment, while miR-205 inhibition led to increased RHPN2 mRNA and protein expression (Fig. 3c-e). Here, RHPN2 is linked to prostate carcinoma.